Dissolution Rate Enhancement by Adsorption of Poorly Soluble Drugs on Hydrophilic Silica Aerogels

References

• Stricker H. Physikalische Pharmazie3rd Ed. Wissenschaftliche Verlagsgesellschaft GmbH, Stuttgart 1998
   Google Scholar
• Sunkara G., Kompella U. B. Drug delivery applications of supercritical fluid technology. Drug Deliv. Technol. 2002; 2: 44–50
   Google Scholar
• Charoenchaitrakool M., Dehghani F., Foster N. R., Chan H. K. Micronization by rapid expansion of supercritical solutions to enhance the dissolution rates of poorly water‐soluble pharmaceuticals. Ind. Eng. Chem. Res. 2000; 39: 4794–4802
   Web of Science ®Google Scholar
• Warwick B., Dehghani F., Foster N. R., Biffin J. R., Regtop H. L. Synthesis, purification, and micronization of pharmaceuticals using the gas antisolvent technique. Ind. Eng. Chem. Res. 2000; 39: 4571–4579
   Web of Science ®Google Scholar
• Rasenack N., Mueller B. W. Dissolution rate enhancement by in situ micronization of poorly water‐soluble drugs. Pharm. Res. 2002; 19: 1894–1900
   PubMed Web of Science ®Google Scholar
• A. M. Hillery, A. Wilboy, J. SwarbrickDrug Delivery and Targeting, . Taylor & Francis. 2001
   Google Scholar
• Yang K. Y., Glemza R., Jarowski C. I. Effects of amorphous silicon dioxides on drug dissolution. J. Pharm. Sci. 1979; 68: 560–565
   PubMed Web of Science ®Google Scholar
• Monkhouse D. C., Lach J. L. Use of adsorbents in enhancement of drug dissolution. I and II. J. Pharm. Sci. 1972; 61: 1431–1441
   Google Scholar
• Abdallah H. Y., Khalafallah N., Khalil S. A. Influence of dispersion method on particle‐size and dissolution of griseofulvin‐silicon dioxide triturations. Drug Dev. Ind. Pharm. 1983; 9(5)795–808
   Web of Science ®Google Scholar
• Carli F., Colombo I. Physical state of drug loaded into silica gel carriers. Acta Pharm. Jugosl. 1988; 38: 361–371
   Google Scholar
• Watanabe T., Wakiyama N., Usui F., Ikeda M., Isobe T., Senna M. Stability of amorphous indomethacin compounded with silica. Int. J. Pharm. 2001; 226: 81–91
   PubMed Web of Science ®Google Scholar
• Watanabe T., Ohno I., Wakiyama N., Kusal A., Senna M. Controlled dissolution properties of indomethacin by compounding with silica. Stp Pharm. Sci. 2002; 12: 363–367
   Google Scholar
• Watanabe T., Hasegawa S., Wakiyama N., Kusai A., Senna M. Comparison between polyvinylpyrrolidone and silica nanoparticles as carriers for indomethacin in a solid state dispersion. Int. J. Pharm. 2003; 250: 283–286
   PubMed Web of Science ®Google Scholar
• Valett‐Regi M., Ramila A., del Real R. P., Perez‐Pariente. Influence of pore size of MCM‐41 Matrices on drug delivery rate. J. Chem. Mater. 2001; 13: 308
   Google Scholar
• Horcajada P., Ramila A., Perez‐Pariente J., Valett‐Regi M. Microporous and mesoporous. Mat 2004; 68: 105–109
   Google Scholar
• J. FrickeAerogels, . Springer, Berlin 1986
   Google Scholar
• Husing N., Schubert U. Organofunctional silica aerogels. J. Sol‐Gel Sci. Technol. 1997; 8: 807–812
   Web of Science ®Google Scholar
• Husing N., Schubert U., Misof K., Fratzl P. Formation and structure of porous gel networks from Si(OMe)(4) in the presence of A(CH2)(n)Si(OR)(3) (A = Functional Group). Chem. Mater. 1998; 10: 3024–3032
   Web of Science ®Google Scholar
• , Offenlegungsschrift DE 19653758 A1, issued on 12.1996
   Google Scholar
• El Rassy H., Buisson P., Bouali B., Perrard A., Pierre A. C. Surface characterization of silica aerogels with different proportions of hydrophobic groups, dried by the CO2 supercritical method. Langmuir 2003; 19: 358–363
   Web of Science ®Google Scholar
• Lee K. H., Kim S. Y., Yoo K. P. Low‐density, hydrophobic aerogels. J. Non‐Cryst. Solids 1995; 186: 18–22
   Web of Science ®Google Scholar
• Pauthe M., Despetis F., Phalippou J. Hydrophobic silica CO2 aerogels. J. Non‐Cryst. Solids 1993; 155: 110–114
   Web of Science ®Google Scholar
• Rao A. V., Kalesh R. R., Amalnerkar D. P., Seth T. Synthesis and characterization of hydrophobic TMES/TEOS based silica aerogels. J. Porous Mater. 2003; 10: 23–29
   Web of Science ®Google Scholar
• Schwertfeger F., Zimmermann A., Krempel H. Use of Inorganic Aerogels in Pharmacy. U.S. Patent 6,280,744, 2001
   Google Scholar
• Berg A., Droege M. W., Fellmann J. D., Klaveness J., Rongved P. Medical Use of Organic Aerogels and Biodegradable Organic Aerogels. WO Patent 95/01165, 1995
   Google Scholar
• Lee K., Gould G. Aerogel Powder Therapeutic Agents. WO Patent 02/051389 A2, 2001
   Google Scholar
• Ayers M. R., Hunt A. J. Synthesis and properties of chitosan‐silica hybrid aerogels. J. Non‐Cryst. Solids 2001; 285: 123–127
   Web of Science ®Google Scholar
• Basso A., DeMartin L., Ebert C., Gardossi L., Tomat A., Casarci M., Rosi O. L. A novel support for enzyme adsorption: properties and applications of aerogels in low water media. Tetrahedron Lett. 2000; 41: 8627–8630
   Web of Science ®Google Scholar
• Buisson P., Hernandez C., Pierre M., Pierre A. C. Encapsulation of lipases in aerogels. J. Non‐Cryst. Solids 2001; 285: 295–302
   Web of Science ®Google Scholar
• Power M., Hosticka B., Black E., Daitch C., Norris P. Aerogels as biosensors: viral particle detection by bacteria immobilized on large pore aerogel. J. Non‐Cryst. Solids 2001; 285: 303–308
   Web of Science ®Google Scholar
• Wallace J. M., Rice J. K., Pietron J. J., Stroud R. M., Long J. W., Rolison D. R. Silica nanoarchitectures incorporating self‐organized protein superstructures with gas‐phase bioactivity. Nano Lett. 2003; 3: 1463–1467
   Web of Science ®Google Scholar
• Smirnova I., Arlt W. Synthesis of silica aerogels: influence of the supercritical CO2 on the sol‐gel process. J. Sol‐Gel Sci. Technol. 2003; 28(2)175–184
   Web of Science ®Google Scholar
• FIP Guidelines for Dissolution Testing of Solid Oral Products. Final Draft. Drug Inf. J. 1996; 30: 1071–1084
   Google Scholar
• Bartle K. D., Clifford A. A., Jafar S. A., Shilstone G. F. Solubilities of solids and liquids of low volatility in supercritical CO2. J. Phys. Chem. Ref. Data 1991; 20: 713–756
   Web of Science ®Google Scholar
• Vandana V., Teja A. S. The solubility of paclitaxel in supercritical CO2 and N2O. Fluid Phase Equilib. 1997; 135: 83–88
   Web of Science ®Google Scholar
• Vetere A. A short‐cut method to predict the solubilities of solids in supercritical carbon dioxide. Fluid Phase Equilib. 1998; 148: 83–93
   Web of Science ®Google Scholar
• Stassi A., Bettini R., Gazzaniga A., Giordano F., Schiraldi A. Assessment of solubility of ketoprofen and vanillic acid in supercritical CO2 under dynamic conditions. J. Chem. Eng. Data 2000; 45(2)161–165
   Web of Science ®Google Scholar
• Domingo C., Garcia‐Carmona J., Fanovich M. A., Llibre J., Rodriguez‐Clemente R. Single‐ or two‐solute adsorption process at supercritical conditions: an experimental study. J. Supercrit. Fluids 2001; 21: 147–157
   Web of Science ®Google Scholar
• Magnan C., Bazan C., Charbit F., Joachim J., Charbit G. Ph. Rudolph, Ch. TreppImpregnation of porous substrate with active substances by means of supercritical fluids. High Pressure Chemical Engineering, . Elsevier. 1996; 509–514
   Google Scholar
• K. FloreyAnalytical Profiles of Drug Substances: Ketoprofen, . Academic Press. 1981; Vol. 10: 443–471
   Google Scholar
• K. FloreyAnalytical Profiles of Drug Substances: Griseofulvin, . Academic Press. 1979; Vol. 8: 218–249
   Google Scholar
• Gupta M. K., Vanwert A., Bogner R. H. Formation of physically stable amorphous drugs by millig with neusilin. J. Pharm. Sci. 2003; 92: 536–551
   PubMed Web of Science ®Google Scholar
• , Food and Drug Administration. HHS. § 436.317, 21 CFR Ch.1, 1998
   Google Scholar
• Atkinson R. M., Bedford C., Child K. J., Tomich E. G. Effect of particle size on blood griseofulvin‐levels in man. Nature 1962; 193: 4815–4816
   Web of Science ®Google Scholar
• Türk M., Hils P., Helfgen B., Schaber K., Martin H. J., Wahl M. A. Micronization of pharmaceutical substances by the rapid expansion of supercritical solutions (RESS). J. Supercrit. Fluids 2002; 22: 75–84
   Web of Science ®Google Scholar